PF-06733804 is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key compound in the development of therapeutic agents targeting specific biological pathways. Its application is particularly significant in the study of enzyme inhibition, where it is used to modulate enzymatic activity in various disease models. Researchers employ this compound to investigate its efficacy in treating conditions such as inflammatory diseases, cancer, and metabolic disorders. Additionally, PF-06733804 is explored for its potential in enhancing drug delivery systems, improving the bioavailability of active pharmaceutical ingredients. Its role in preclinical studies helps in understanding the pharmacokinetics and pharmacodynamics of new drug candidates, contributing to the advancement of novel treatments.